AB Sciex, U. of Wollongong Partner on Lipidomics Research | GenomeWeb

NEW YORK (GenomeWeb News) – AB Sciex and the University of Wollongong in Australia today announced a research partnership aimed at developing lipid analysis capabilities.

The deal provides AB Sciex, a Danaher company, with an exclusive license to the university's ozone-induced dissociation, or OzID, intellectual property, a technology that allows for a better understanding of lipid structure more quickly and in greater detail than is possible with other technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.